| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
- Achieve Life Sciences, Inc. (NASDAQ:ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline for treatment of nicotine dependence for smoking cessation, today announced the promotion of Craig Donnelly to Chief Operations Officer.
Mr. Donnelly has been with Achieve since 2022, serving as Executive Vice President, Chemistry, Manufacturing, and Controls (CMC) and Regulatory CMC. In his expanded role as Chief Operations Officer, Mr. Donnelly will lead the integration of Achieve's supply chain and manufacturing activities with the commercial strategy in anticipation of a product launch in mid-late 2026. This responsibility involves optimizing operations efficiency in the company's manufacturing, supply chain, CMC operations and product life-cycle management, while ensuring the company maintains the highest standards of quality and regulatory compliance. His leadership will be essential in establishing the scalable commercial manufacturing processes and systems needed to support Achieve's transition from a late-stage development company to the anticipated commercial launch of cytisinicline.
Posted In: ACHV
